228 related articles for article (PubMed ID: 20661913)
1. Perspective on updated treatment guidelines for patients with gastrointestinal stromal tumors.
Blay JY; von Mehren M; Blackstein ME
Cancer; 2010 Nov; 116(22):5126-37. PubMed ID: 20661913
[TBL] [Abstract][Full Text] [Related]
2. Gastrointestinal stromal tumors (GISTs): an updated experience.
Machairas A; Karamitopoulou E; Tsapralis D; Karatzas T; Machairas N; Misiakos EP
Dig Dis Sci; 2010 Dec; 55(12):3315-27. PubMed ID: 20725786
[TBL] [Abstract][Full Text] [Related]
3. Imatinib mesylate: in the treatment of gastrointestinal stromal tumours.
Croom KF; Perry CM
Drugs; 2003; 63(5):513-22; discussion 523-4. PubMed ID: 12600228
[TBL] [Abstract][Full Text] [Related]
4. Gastrointestinal stromal tumors: imatinib and beyond.
Schnadig ID; Blanke CD
Curr Treat Options Oncol; 2006 Nov; 7(6):427-37. PubMed ID: 17032555
[TBL] [Abstract][Full Text] [Related]
5. Developments in targeted therapy of advanced gastrointestinal stromal tumors.
Rutkowski P; Symonides M; Zdzienicki M; Siedlecki JA
Recent Pat Anticancer Drug Discov; 2008 Jun; 3(2):88-99. PubMed ID: 18537751
[TBL] [Abstract][Full Text] [Related]
6. Tyrosine kinase inhibitors in the treatment of unresectable or metastatic gastrointestinal stromal tumors.
Nishida T; Doi T; Naito Y
Expert Opin Pharmacother; 2014 Oct; 15(14):1979-89. PubMed ID: 24990162
[TBL] [Abstract][Full Text] [Related]
7. Clinical practice guidelines for gastrointestinal stromal tumor (GIST) in Japan: English version.
Nishida T; Hirota S; Yanagisawa A; Sugino Y; Minami M; Yamamura Y; Otani Y; Shimada Y; Takahashi F; Kubota T;
Int J Clin Oncol; 2008 Oct; 13(5):416-30. PubMed ID: 18946752
[TBL] [Abstract][Full Text] [Related]
8. The standard diagnosis, treatment, and follow-up of gastrointestinal stromal tumors based on guidelines.
Nishida T; Blay JY; Hirota S; Kitagawa Y; Kang YK
Gastric Cancer; 2016 Jan; 19(1):3-14. PubMed ID: 26276366
[TBL] [Abstract][Full Text] [Related]
9. Molecular mechanisms of secondary imatinib resistance in patients with gastrointestinal stromal tumors.
Wang CM; Huang K; Zhou Y; Du CY; Ye YW; Fu H; Zhou XY; Shi YQ
J Cancer Res Clin Oncol; 2010 Jul; 136(7):1065-71. PubMed ID: 20043176
[TBL] [Abstract][Full Text] [Related]
10. Update on the biology and therapy of gastrointestinal stromal tumors.
D'Amato G; Steinert DM; McAuliffe JC; Trent JC
Cancer Control; 2005; 12(1):44-56. PubMed ID: 15668652
[TBL] [Abstract][Full Text] [Related]
11. The role of KIT in the management of patients with gastrointestinal stromal tumors.
Hornick JL; Fletcher CD
Hum Pathol; 2007 May; 38(5):679-87. PubMed ID: 17437861
[TBL] [Abstract][Full Text] [Related]
12. Primary and secondary kinase genotypes correlate with the biological and clinical activity of sunitinib in imatinib-resistant gastrointestinal stromal tumor.
Heinrich MC; Maki RG; Corless CL; Antonescu CR; Harlow A; Griffith D; Town A; McKinley A; Ou WB; Fletcher JA; Fletcher CD; Huang X; Cohen DP; Baum CM; Demetri GD
J Clin Oncol; 2008 Nov; 26(33):5352-9. PubMed ID: 18955458
[TBL] [Abstract][Full Text] [Related]
13. Imatinib treatment for gastrointestinal stromal tumour (GIST).
Lopes LF; Bacchi CE
J Cell Mol Med; 2010 Jan; 14(1-2):42-50. PubMed ID: 19968734
[TBL] [Abstract][Full Text] [Related]
14. NCCN Task Force report: management of patients with gastrointestinal stromal tumor (GIST)--update of the NCCN clinical practice guidelines.
Demetri GD; Benjamin RS; Blanke CD; Blay JY; Casali P; Choi H; Corless CL; Debiec-Rychter M; DeMatteo RP; Ettinger DS; Fisher GA; Fletcher CD; Gronchi A; Hohenberger P; Hughes M; Joensuu H; Judson I; Le Cesne A; Maki RG; Morse M; Pappo AS; Pisters PW; Raut CP; Reichardt P; Tyler DS; Van den Abbeele AD; von Mehren M; Wayne JD; Zalcberg J;
J Natl Compr Canc Netw; 2007 Jul; 5 Suppl 2():S1-29; quiz S30. PubMed ID: 17624289
[TBL] [Abstract][Full Text] [Related]
15. Current management of gastrointestinal stromal tumors--a comprehensive review.
Lai EC; Lau SH; Lau WY
Int J Surg; 2012; 10(7):334-40. PubMed ID: 22633986
[TBL] [Abstract][Full Text] [Related]
16. Duodenal gastrointestinal stromal tumor: From clinicopathological features to surgical outcomes.
Marano L; Boccardi V; Marrelli D; Roviello F
Eur J Surg Oncol; 2015 Jul; 41(7):814-22. PubMed ID: 25956211
[TBL] [Abstract][Full Text] [Related]
17. [Treatment progress of gastrointestinal stromal tumor].
Ji X; Ji JF
Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Mar; 16(3):292-6. PubMed ID: 23536354
[TBL] [Abstract][Full Text] [Related]
18. Advanced gastrointestinal stromal tumor in Europe: a review of updated treatment recommendations.
Blay JY; Reichardt P
Expert Rev Anticancer Ther; 2009 Jun; 9(6):831-8. PubMed ID: 19496720
[TBL] [Abstract][Full Text] [Related]
19. [Gastrointestinal stromal tumour (GIST): current standards in multimodal management].
Reichardt P; Reichardt A
Zentralbl Chir; 2011 Aug; 136(4):359-63. PubMed ID: 21863513
[TBL] [Abstract][Full Text] [Related]
20. Identification and treatment of chemoresistant inoperable or metastatic GIST: experience with the selective tyrosine kinase inhibitor imatinib mesylate (STI571).
Demetri GD
Eur J Cancer; 2002 Sep; 38 Suppl 5():S52-9. PubMed ID: 12528773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
